Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsHematopoietic Stem CellsTransplantation ConditioningBlood BanksGraft vs Host DiseaseAntigens, CD34Hematologic NeoplasmsHematopoietic Stem Cell MobilizationSpinal CordBone Marrow TransplantationGraft SurvivalMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCell DifferentiationTransplantation ChimeraTreatment OutcomeCombined Modality TherapyTissue DonorsMyeloablative AgonistsBusulfanSpinal Cord InjuriesMultiple MyelomaMice, SCIDCyclophosphamideHistocompatibility TestingBlood Component RemovalRecurrenceCells, CulturedRemission InductionAntineoplastic Combined Chemotherapy ProtocolsHistocompatibilityWhole-Body IrradiationLiver TransplantationLeukemiaUmbilical CordImmunosuppressive AgentsHematopoiesisRetrospective StudiesMesenchymal Stem Cell TransplantationLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingVidarabineDisease-Free SurvivalGraft vs Leukemia EffectTime FactorsInfectionEtoposideSurvival RateCell TransplantationThiotepaHematologic DiseasesSurvival AnalysisBlood CellsLeukemia, Myeloid, AcuteSalvage TherapyTransplantation, IsogeneicEmbryonic Stem CellsInfant, NewbornMice, Inbred NODKidney TransplantationPOEMS SyndromeAmyloidosisHLA AntigensMyelodysplastic SyndromesHodgkin DiseaseAdult Stem CellsAnemia, AplasticCytomegalovirus InfectionsFollow-Up StudiesCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaVincristineImmunophenotypingFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow CellsBlood Cell CountLymphomaCarmustineAntigens, CDTransplantation ImmunologyBlood DonorsFlow CytometryLymphocyte DepletionCell SeparationPlatelet CountMesenchymal Stromal CellsUnrelated DonorsIfosfamideCell Lineage